Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug - Eli Lilly ( NYSE:LLY ) , Amgen ( NASDAQ:AMGN )
Shares of Terns Pharmaceuticals TERN, a clinical-stage company, soared 16.8% after the company announced positive top-line data from the early-stage single and multiple-ascending dose ( SAD and MAD ) obesity study.
| Ticker |
Sentiment |
Impact |
|
LLY
|
Somewhat Bullish
|
27 %
|
|
TERN
|
Neutral
|
73 %
|
|
GS
|
Somewhat Bullish
|
5 %
|
|
AMGN
|
Neutral
|
22 %
|
|
NVO
|
Neutral
|
22 %
|
